entertainment -WSS

entertainment

author：entertainment 2025-09-03 14:43:28 - browse：6

photo of a person's brown eye -- health coverage from STAT — Adobe

In the clinical trial, the gene therapy seemed to be helping the boy’s skin wounds heal. But, his doctors wondered, could it also help his eyes?

The boy, Antonio Vento Carvajal, had a genetic condition called epidermolysis bullosa, or EB, which causes the skin to be so fragile that even the slightest friction can cause blisters or tears. Antonio, like some patients, also had eye issues as a result of the disease.

His eyelids were fusing to the eyes themselves. The eyes’ white tissue was growing over his corneas. The problems caused his vision to deteriorate to the point that, in his right eye, he could detect nothing more than the motion of someone waving a hand in front of his face.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： BMI, flaws aside, is found to be useful estimate of body fat in youth

WSS

See how much Covid

In science, is the line between industry and academia shifting?

Study finds new variant for Parkinson’s in African populations

Winners, losers from Medicare’s list of drugs subject to price talks

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Medicare explains how it will choose drugs for negotiation

knowledge

entertainment

hotspot

Supreme Court strikes down use of affirmative action

Australia’s approach to dialysis celebrates life

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why more medical students aren't specializing in primary care

Anesthesiologist group: stop taking Ozempic before surgery

HIV drugs protect against transmission, even in unprotected sex

Sports medicine is finally prioritizing gender equality

Woman returns to dialysis after doctors remove transplanted pig kidney

Trump demands the U.S. pay no more for drugs than other countries … again

How a symptom of dementia informs our understanding of creativity

leisure time

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Diversity in medical illustrations gets boost from Chidiebere Ibe

Shifting the focus from loneliness to social health

Innovation in antibiotics is ailing. 'Brain drain' may kill it

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Medicare explains how it will choose drugs for negotiation

Wikipedia

leisure time

entertainment

explore